Cost Of Revenue - Elos Medtech AB (STO:ELOS B) - Alpha Spread

Elos Medtech AB
STO:ELOS B

Watchlist Manager
Elos Medtech AB Logo
Elos Medtech AB
STO:ELOS B
Watchlist
Price: 203 SEK 1.5% Market Closed
Market Cap: 5.5B SEK
Have any thoughts about
Elos Medtech AB?
Write Note

Elos Medtech AB
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Elos Medtech AB
Cost of Revenue Peer Comparison

Comparables:
EKTA B
S
SUS
CEVI
GETI B
ARJO B

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Elos Medtech AB
STO:ELOS B
Cost of Revenue
-kr578.1m
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Cost of Revenue
-kr11.3B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Cost of Revenue
-kr264m
CAGR 3-Years
-130%
CAGR 5-Years
-73%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Cost of Revenue
-kr242.4m
CAGR 3-Years
-15%
CAGR 5-Years
-19%
CAGR 10-Years
-12%
Getinge AB
STO:GETI B
Cost of Revenue
-kr17.3B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Cost of Revenue
-kr6.2B
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
N/A

See Also

What is Elos Medtech AB's Cost of Revenue?
Cost of Revenue
-578.1m SEK

Based on the financial report for Dec 31, 2022, Elos Medtech AB's Cost of Revenue amounts to -578.1m SEK.

What is Elos Medtech AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-7%

Over the last year, the Cost of Revenue growth was -24%. The average annual Cost of Revenue growth rates for Elos Medtech AB have been -7% over the past three years , -7% over the past five years .

Back to Top